Switzerland
Research Article
In Ovo Progression of Borderline Ovarian Tumors
Author(s): Meynier S, Undurraga M, Tille JC, Petignat P and Cohen MMeynier S, Undurraga M, Tille JC, Petignat P and Cohen M
Objective: Borderline ovarian tumors (BOTs) are generally considered to be non-invasive tumors with low malignancy potential. However, studies show that BOTs have the ability to progress to low-grade carcinomas and gain the potential to invade surrounding tissue and to metastasize. Here, we investigate whether a patient derived serous BOT (SBOT) could progress in low-grade serous carcinoma (LGSC) through in vitro and in vivo characterization.
Methods: Ovarian cancer cell line from a SBOT, named OCAM, were isolated and characterized by PCR, migration assay and chick chorioallantoic membrane (CAM) assay.
Results: OCAM cells express carcinoma characteristics and form a tumor in CAM. Moreover, OCAM cells get into membra.. Read More»
DOI:
10.4172/2476-2261.1000109
Journal of Oncology Translational Research received 93 citations as per Google Scholar report